Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenues, net $ 3,179 $ 2,934 $ 9,515 $ 8,625
Cost of revenues 2,054 1,691 6,221 4,935
Gross margin 1,125 1,243 3,294 3,690
Operating expenses:        
Research and development 7 20 8
Selling, general and administrative 3,664 1,961 9,277 5,820
Total operating expenses 3,664 1,968 9,297 5,828
Loss from operations (2,539) (725) (6,003) (2,138)
Other income (expense):        
Interest income (expense), net (2,935) 10 (5,203) (32)
Changes in fair value of derivative liability and warrant modification expense 4,656 9 6,091 113
Loss on issuance of convertible debt (402) (824)
Other income (expense) 127 59 367 92
Total other income (expense), net 1,446 78 431 173
Loss before income taxes (1,093) (647) (5,572) (1,965)
Income tax expense  
Net loss (1,093) (647) (5,572) (1,965)
Less: Income attributable to non-controlling interest in joint venture (19) (6) (104) (65)
Net loss attributable to NexGel stockholders $ (1,112) $ (653) $ (5,676) $ (2,030)
Net loss per common share - basic $ (2.28) $ (1.64) $ (12.61) $ (5.23)
Net loss per common share - diluted $ (2.28) $ (1.64) $ (12.61) $ (5.23)
Weighted average shares used in computing net loss per common share - basic 487,357 398,565 450,181 387,871
Weighted average shares used in computing net loss per common share – diluted 487,357 398,565 450,181 387,871